(Q48215909)

9 February 2018

title

Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users (English)

1 reference

9 February 2018

author

Carles Soriano-Mas

2

1 reference

9 February 2018

Sagnik Bhattacharyya

6

1 reference

9 February 2018

Albert Batalla Cases

object named as

Albert Batalla

1

0 references

author name string

Marina López-Solà

3

1 reference

9 February 2018

Marta Torrens

4

1 reference

9 February 2018

José A Crippa

5

1 reference

9 February 2018

Laura Blanco-Hinojo

7

1 reference

9 February 2018

Ana B Fagundo

8

1 reference

9 February 2018

Ben J Harrison

9

1 reference

9 February 2018

Santiago Nogué

10

1 reference

9 February 2018

Rafael de la Torre

11

1 reference

9 February 2018

Magí Farré

12

1 reference

9 February 2018

Jesús Pujol

13

1 reference

9 February 2018

Rocío Martín-Santos

14

1 reference

9 February 2018

publication date

14 January 2013

1 reference

9 February 2018

published in

Addiction Biology

1 reference

9 February 2018

volume

19

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

722-732

1 reference

9 February 2018

Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study.

cites work

1 reference

No association of COMT (Val158Met) genotype with brain structure differences between men and women

21 January 2018

1 reference

Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing

21 January 2018

1 reference

Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology

21 January 2018

1 reference

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis

21 January 2018

1 reference

Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes

21 January 2018

1 reference

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum

21 January 2018

1 reference

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

21 January 2018

1 reference

Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study.

21 January 2018

1 reference

Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain

21 January 2018

1 reference

Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls

21 January 2018

1 reference

Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor.

21 January 2018

1 reference

The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults

21 January 2018

1 reference

Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism

21 January 2018

1 reference

BDNF gene expression is reduced in the frontal cortex of dopamine transporter knockout mice

21 January 2018

1 reference

A voxel-based morphometric study of ageing in 465 normal adult human brains

21 January 2018

1 reference

Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas

21 January 2018

1 reference

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition

21 January 2018

1 reference

Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies

21 January 2018

1 reference

Impact of interacting functional variants in COMT on regional gray matter volume in human brain

21 January 2018

1 reference

Distribution of catechol-O-methyltransferase expression in human central nervous system

21 January 2018

1 reference

Effects of frequent cannabis use on hippocampal activity during an associative memory task

21 January 2018

1 reference

Neurocircuitry of addiction

21 January 2018

1 reference

Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems

21 January 2018

1 reference

Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2.

21 January 2018

1 reference

Structural MRI findings in long-term cannabis users: what do we know?

21 January 2018

1 reference

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

Neurochemical basis of cannabis addiction.

21 January 2018

1 reference

Neuroimaging in cannabis use: a systematic review of the literature

21 January 2018

1 reference

Altered brain tissue composition in heavy marijuana users

21 January 2018

1 reference

Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.

21 January 2018

1 reference

The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.

21 January 2018

1 reference

The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology.

21 January 2018

1 reference

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients

21 January 2018

1 reference

Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.

21 January 2018

1 reference

Neurotoxic relationship between dopamine and iron in the striatal dopaminergic nerve terminals.

21 January 2018

1 reference

Substance use and regional gray matter volume in individuals at high risk of psychosis

21 January 2018

1 reference

Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia

21 January 2018

1 reference

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.

21 January 2018

1 reference

Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond

21 January 2018

1 reference

Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report

21 January 2018

1 reference

Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study

21 January 2018

1 reference

Regional brain abnormalities associated with long-term heavy cannabis use.

21 January 2018

1 reference

The COMT val158met polymorphism and brain morphometry in healthy young adults

21 January 2018

1 reference

Cerebellar white-matter changes in cannabis users with and without schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ADB.12027

1 reference

9 February 2018

1 reference

9 February 2018